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Review
To examine whether particulate matter (PM) 
differentially affects certain populations, epi­
demiological studies often conduct stratified 
analyses, where a greater association between 
PM and the health effect being examined in 
one subgroup compared with another pro­
vides evidence for a population that may be 
more susceptible to PM­related health effects. 
Additionally, controlled human exposure 
and toxicological studies can provide sup­
porting evidence through the examination 
of individuals with underlying disease and 
animal models of disease, respectively. Often 
the terms “susceptible” and “vulnerable” have 
been used to characterize these subgroups; 
however, inconsistency and overlap in these 
definitions complicate the identification of 
populations that may be at greatest risk.
In this review, we integrate the evidence 
from recent epidemiological studies with 
supporting evidence from controlled human 
exposure and toxicological studies to identify 
the characteristics of populations susceptible 
to PM­related health effects. This review is 
not intended to be an exhaustive overview of 
the recent PM literature, but instead a com­
prehensive evaluation of studies that exam­
ined characteristics of potentially susceptible 
populations.
Defining Susceptibility
The concept of susceptibility is derived 
from the interindividual variation in human 
responses to air pollutants, resulting in 
some populations being at increased risk for 
air­pollutant–related health effects (Kleeberger 
and Ohtsuka 2005). “Susceptibility” and 
“vulnerability” have often been used as dis­
tinct terms for identifying these populations, 
with “susceptibility” referring to biological 
or intrinsic factors (e.g., life stage, sex) and 
“vulnerability” referring to nonbiological or 
extrinsic factors [e.g., socioeconomic status 
(SES), differential exposure]. However, their 
definitions vary across reports and studies. We 
provide some examples below.
•	American Lung Association (2001). 
Susceptible: greater likelihood of an adverse 
outcome given a specific exposure, com­
pared with the general population; includes 
both host and environmental factors (e.g., 
genetics, diet, physiologic state, age, and sex, 
social, economic, and geographic attributes). 
Vulnerable: periods during an individual’s life 
when they are more susceptible to environ­
mental exposures.
•	Kleeberger and Ohtsuka (2005). Susceptible: 
intrinsic [e.g., age, sex, preexisting disease 
(e.g., asthma) and genetics] and extrinsic 
(e.g., previous exposure and nutritional   
status) factors.
•	Pope and Dockery (2006). Susceptible: charac­
teristics that contribute to increased risk of 
PM­related health effects (e.g., genetics, pre­
existing disease, age, sex, race, SES, health­
care availability, educational attainment, and 
housing characteristics).
•	Porta (2008). Susceptible: vulnerability; lack 
of resistance to disease; the dynamic state of 
being more likely or liable to be harmed by 
a health determinant. Vulnerable: a position 
of relative disadvantage, for example, because 
of impaired nutrition, cognition, or social 
position. The extent to which a person, popu­
lation, or ecosystem is unable or unlikely to 
respond to threats; may be used as a synonym 
for “susceptibility.”
In addition, the terms “at­risk population” 
and “sensitive population” have been used 
in the literature to encompass these concepts 
more generally.
In many instances, a characteristic that 
increases a population’s risk for morbidity or 
mortality due to exposure to an air pollut­
ant (e.g., PM) cannot be easily categorized 
as solely a susceptibility or vulnerability fac­
tor due to their overlapping nature, which 
contributes to the complexity surrounding 
these concepts. Thus, we developed an all­
encompassing definition for the term “sus­
ceptible population” as it relates to PM: 
individual­ and population­level characteris­
tics that increase the risk of PM­related health 
effects in a population, including, but not 
limited to, genetic background, birth out­
comes (e.g., low birth weight, birth defects), 
race, sex, life stage, lifestyle (e.g., smoking 
status, nutrition), preexisting disease, SES 
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(e.g., educational attainment, reduced access to 
health care), and characteristics that may mod­
ify exposure to PM (e.g., time spent outdoors). 
Rather than focusing on whether a population 
is susceptible or vulnerable, we focus instead 
on the relevant question: which individual­ 
and population­level characteristics result in 
increased risk of PM­related health effects?
Study Selection
To identify potentially susceptible popula­
tions, we focused on the collective evidence 
evaluated in the most recent science review 
of the PM National Ambient Air Quality 
Standards (NAAQS) [U.S. Environmental 
Protection Agency (EPA) 2009], building 
upon the evidence presented in previous PM 
NAAQS reviews (e.g., U.S. EPA 2004). The 
studies considered [see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002255)] exam­
ined the health effects due to short­term 
exposure (i.e., hours to multiple days) and 
long­term exposure (i.e., months to years) to 
either both the fine PM fraction [aerodynamic 
diameter ≤ 2.5 µm (PM2.5)] and coarse PM 
fraction [aerodynamic diameter between 10 
and 2.5 µm (PM10–2.5)] or only one size frac­
tion. Studies that focused on exposure to the 
thoracic PM fraction [aerodynamic diameter 
≤ 10 µm (PM10)] are also discussed to the 
extent that they are informative regarding 
health effects related to PM2.5 and PM10–2.5 
exposures.
We focused on epidemiological studies 
that presented stratified results (e.g., males vs. 
females or < 65 vs. ≥ 65 years of age) because 
this allowed us to compare populations 
exposed to similar PM concentrations within 
the same study design. Results from epidemio­
logical studies provided the basis for charac­
terizing populations potentially susceptible to 
PM­related health effects. We recognize that 
epidemiological studies that focus on only one 
potentially susceptible population (e.g., individ­
uals ≥ 65 years of age or children) may provide 
supporting evidence on whether a population 
is susceptible to PM­related health effects, but 
we do not discuss these studies in this review 
because of the lack of a comparison population.
We also evaluated controlled human 
exposure studies that examined individuals 
with a preexisting disease, and toxicological 
studies that used animal models of disease. 
We used these studies to determine whether 
there was coherence of effects across the scien­
tific disciplines, and to examine biological 
plausibility for the characteristics identified in 
epidemiological studies that may confer sus­
ceptibility to PM­related health effects. This 
approach allowed us to evaluate controlled 
human exposure and toxicological studies that 
either included or did not include a com­
parison population. Collectively, the results 
from stratified analyses in epidemiological 
studies along with supporting evidence from 
controlled human exposure and toxicological 
studies form the overall weight of evidence 
that we used to assess whether specific charac­
teristics result in a population being suscep­
tible to PM­related health effects.
Life Stage
Occurrence of disease is a reflection of the 
interaction between host and environmen­
tal factors, which varies over time (American 
Lung Association 2001). Specific populations, 
particularly children and older adults, are 
identified as potentially more susceptible than 
the general population to PM­induced effects 
as a result of physiological differences.
Children. Children exposed to comparable 
levels of PM are potentially more susceptible 
than are adults because of greater time spent 
outdoors, activity levels, and minute volume 
per unit body weight, all of which can lead to 
an increased PM dose per lung surface area 
and adverse effects on the developing lungs 
(U.S. EPA 2004). Recent epidemiological 
studies examined the association between PM 
and childhood respiratory effects. Collectively, 
evidence supports increased respiratory effects 
(e.g., wheeze, cough, respiratory hospital 
admissions) from short­term PM exposure of 
all size fractions in children (i.e., < 18 years) 
compared with adults (e.g., Host et al. 2007; 
Peel et al. 2005).
Toxicological studies provide support for 
a biologically plausible mechanism for the 
increased risk of respiratory effects in children. 
Altered lung development (i.e., structure and 
function) was observed in mice chronically 
exposed to ambient urban air during pre­
natal and postneonatal periods (Mauad et al. 
2008). Additionally, a study demonstrated 
that exposure of neonatal rats to iron­soot PM 
resulted in reduced cellular proliferation in 
certain regions of the lung (e.g., Pinkerton 
et al. 2008). Together these studies suggest 
that exposure to PM during critical develop­
mental periods may result in impaired growth 
of the respiratory system.
Older adults. Older adults are generally 
considered a susceptible population because 
of the gradual decline in physiological pro­
cesses over time (U.S. EPA 2006). For exam­
ple, dosimetric studies show reduced clearance 
of PM in all regions of the respiratory tract 
with increasing age beyond young adulthood 
(U.S. EPA 2009). Older adults also represent 
a potentially susceptible population compared 
with children or younger adults because of the 
higher prevalence of preexisting cardiovascular 
and respiratory diseases, which may also confer 
susceptibility to PM.
Epidemiological evidence indicates 
increased risk of cardiovascular morbidity with 
short­term PM exposure in older adults. Several 
studies reported increased cardiovascular 
disease (CVD) hospital admissions among 
older adults compared with all ages or ages 
< 65 years when exposed to PM2.5 (e.g., Pope 
et al. 2008), PM10–2.5 (e.g., Host et al. 2007), 
and PM10 (e.g., Larrieu et al. 2007). However, 
some studies also revealed no evidence for 
increased risk of cardiovascular­related hospital 
admissions among older adults compared with 
younger ages for PM2.5 (e.g., Metzger et al. 
2004) or PM10 (e.g., Zanobetti and Schwartz 
2005). Studies that have examined respiratory­
related effects among older adults have not 
consistently shown associations with PM expo­
sure, but some have reported an increase in 
respiratory­related hospital admissions (e.g., 
Fung et al. 2005).
Although the results from the epidemio­
logical literature are mixed regarding morbid­
ity effects from PM exposure, the evidence 
from controlled human exposure and toxico­
logical studies provides biological plausibility 
for PM­related cardiovascular effects in older 
adults. Controlled human exposure studies 
revealed decreased heart rate variability (HRV) 
in older adults with or without chronic obstruc­
tive pulmonary disease (COPD) after PM2.5 
concentrated ambient particle (CAPs) expo­
sure (Devlin et al. 2003; Gong et al. 2004a). 
Using an animal model of terminal senescence, 
Tankersley et al. (2008) demonstrated altered 
baseline autonomic tone, reductions in car­
diac fractional shortening, and pulmonary vas­
cular congestion after carbon black exposure. 
Additionally, arrhythmias have been observed 
in older, but not younger, rats exposed to 
PM2.5 CAPs (Nadziejko et al. 2004).
The continuum of effects from subclinical 
to cardiovascular­ or respiratory­related hos­
pitalization and ultimately death is supported 
by epidemiological studies showing that older 
adults (i.e., ≥ 75 years of age in these studies) 
are more susceptible to nonaccidental mortal­
ity upon short­term exposure to PM2.5 (e.g., 
Franklin et al. 2007) and PM10 (e.g., Zeka 
et al. 2006b) compared with younger ages 
(i.e., < 75 years of age). Similar results were 
observed in long­term PM2.5 exposure studies 
(e.g., Naess et al. 2007).
Sex
Evidence is not consistent for a difference in 
PM­related health effects by sex. However, 
results from dosimetric studies demonstrate 
sex­related differences in the localization of 
particles when deposited in the respiratory tract 
and in the deposition rate due to differences in 
body size, conductive airway size, and ventila­
tory parameters (U.S. EPA 2004). Specifically, 
females have proportionally smaller airways 
and slightly greater airway reactivity than do 
males (Yunginger et al. 1992).
Relatively few epidemiological studies (i.e., 
reviewed in U.S. EPA 2009) have conducted 
sex­stratified analyses, and these results are Sacks et al.
448  v o l u m e  119 | n u m b e r 4 | April 2011  •  Environmental Health Perspectives
not consistent with the findings of dosimet­
ric studies. When examining the association 
between short­ and long­term PM2.5 exposure 
and cause­specific mortality, existing evidence 
suggests slightly increased risk for females for 
nonaccidental mortality (Franklin et al. 2007; 
Ostro et al. 2006), cardiovascular­related 
mortality (Chen et al. 2005; Franklin et al. 
2007), and lung cancer mortality (Naess et al. 
2007), whereas males were at increased risk 
for respiratory­related mortality (Franklin et al. 
2007; Naess et al. 2007). Similarly, associa­
tions between short­term exposure to PM10–2.5 
and nonaccidental and cardiovascular mortality 
were stronger among females than among males 
(Malig and Ostro 2009). Collectively, the PM10 
results (e.g., Chen et al. 2005; Middleton et al. 
2008; Wellenius et al. 2006b; Zanobetti and 
Schwartz 2005; Zeka et al. 2006b) do not sup­
port the associations observed in the PM2.5 and 
PM10–2.5 studies. For example, slightly stronger 
associations between PM10 and cardiovascular 
hospital admissions were observed among males 
than among females (Middleton et al. 2008; 
Zanobetti and Schwartz 2005), and stronger 
associations between PM10 and respiratory hos­
pital admissions (Middleton et al. 2008) and 
respiratory mortality (Zeka et al. 2006b) were 
observed among females than among males. 
Although human clinical studies are not typi­
cally powered to detect differences in response 
between males and females, one study reported 
significantly greater decreases in blood mono­
cytes, basophils, and eosinophils in females than 
in males after controlled exposures to ultrafine 
(UF) elemental carbon, suggesting potential 
sex­related differences in subclinical responses 
upon PM exposure (Frampton et al. 2006).
Race/Ethnicity
Findings from recent epidemiological stud­
ies provide evidence that suggests differential 
susceptibility to PM­induced health effects 
across races and ethnicities; however, results 
varied across study locations. The examination 
of short­term PM2.5 exposures and mortal­
ity in nine California counties demonstrated 
an increased risk of mortality for whites and 
Hispanics but not for blacks (Ostro et al. 
2006). An additional analysis in six California 
counties of associations with PM2.5 and vari­
ous PM2.5 components showed increased risk 
of mortality, specifically cardiovascular mor­
tality, in individuals of Hispanic ethnicity 
compared with whites (Ostro et al. 2008). In 
a study in 15 California counties, Hispanics 
were also found to be at increased risk of car­
diovascular mortality with short­term PM10–2.5 
exposures, but not nonaccidental mortality, 
compared with whites (Malig and Ostro 2009). 
Epidemiological studies that examined health 
effects associated with PM10 exposure did not 
examine Hispanic ethnicity or provide clear 
evidence for increased risk in a specific race. 
For example, Zanobetti et al. (2008) found evi­
dence for increased risk of death in other races 
(i.e., all races except white) compared with 
whites in a cohort of individuals with COPD 
in 34 U.S. cities. However, additional multic­
ity studies revealed no evidence for increased 
risk of congestive heart failure (CHF) hospital 
admissions (Wellenius et al. 2006b) or cause­
specific mortality (Zeka et al. 2006b) when 
comparing white with other races or blacks, 
respectively, with short­term PM10 exposure.
Genetic Factors
Of recent interest is the potential for gene–
environment interactions to affect the rela­
tionship between ambient air pollution and 
the development of health effects (Kauffmann 
et al. 2004). Numerous studies evaluated the 
effect of genetic polymorphisms on responses 
to air pollution exposures in both animals 
and humans. Functionally relevant polymor­
phisms in genes can result in a change in the 
amount or function of the protein product 
of that gene. Investigations of gene–environ­
ment interactions often target polymorphisms 
in already identified candidate susceptibil­
ity genes or in genes whose protein products 
are thought to be involved in the biological 
mechanism underlying the adverse effect of an 
air pollutant. Findings from these studies can 
provide insight into mechanisms that confer 
susceptibility to PM­related health effects.
Given evidence that cardiovascular and 
respiratory effects associated with short­term 
PM exposure are mediated by oxidative stress 
(U.S. EPA 2009), new research has focused 
on the glutathione S­transferase (GST) genes, 
which have common, functionally important 
polymorphic alleles that significantly affect anti­
oxidant function in the lung (Schwartz et al. 
2005). Individuals with genotypes that result 
in reduced or absent enzymatic activity are 
likely to have reduced antioxidant defenses and 
potentially increased susceptibility to inhaled 
oxidants and free radicals. Because most popu­
lations have a high frequency of polymorphisms 
in the GST genes, individuals with these poly­
morphisms represent a potentially large sus­
ceptible population (Gilliland et al. 2004). 
Studies of the Normative Aging Study cohort 
showed that individuals with null GST mu 1 
gene (GSTM1) alleles had a larger decrease in 
HRV upon short­term PM2.5 exposure than 
did individuals with at least one functional 
allele (Chahine et al. 2007; Schwartz et al. 
2005). Further, diabetic individuals with null 
compared with functional GSTM1 alleles had 
larger decrements in flow­mediated dilation 
(FMD), suggesting alterations in endothelial 
function (Schneider et al. 2008). A controlled 
human exposure study investigated the effect 
of allergens and diesel exhaust (DE) particles in 
individuals with either null genotypes for the 
GST genes [GSTM1 and the GST theta­1 gene 
(GSTT1)] or single­nucleotide polymorphisms 
(SNPs) in the GST pi 1 gene (GSTP1; i.e., 
codon 105 variants), which are hypothesized 
key regulators of the adjuvant effects of DE on 
allergic responses (Gilliland et al. 2004). The 
common GSTP1 105 variant (i.e., A105G) 
results in an amino acid change from isoleucine 
to valine in the GSTP1 protein and pleiotropic 
effects on enzymatic function (Gilliland et al. 
2004). Gilliland et al. (2004) demonstrated that 
individuals with the GSTM1 null or the GSTP1 
I105 wild­type genotypes were more susceptible 
to allergic inflammation upon exposure to aller­
gen and DE particles than were individuals with 
functional GSTM1 and GSTP1 V105 variant. 
These results provide evidence of a protective 
effect with a GSTP1 polymorphism.
Interactions between GST genes and PM 
exposure were recently considered in studies 
of birth outcomes. An epidemiological study 
examined the association between high PM10 
exposures (i.e., PM10 concentrations ≥ 75th 
percentile of the PM10 distribution) during 
the third trimester of pregnancy and preterm 
delivery (Suh et al. 2008). Results showed that 
women with the GSTM1 null genotype were 
at increased risk of preterm birth compared 
with women who had the functional genotype. 
Additionally, examination of the statistical 
interaction between high PM10 concentra­
tions during the third trimester of pregnancy 
and the presence of the GSTM1 null genotype 
provided evidence of a synergistic effect on the 
risk of preterm delivery.
Another gene involved in antioxidant 
responses, heme oxygenase (decycling) 1 
(HMOX1), has been examined in a recent 
panel study. Chahine et al. (2007) found that 
HRV decreased upon short­term PM2.5 expo­
sure in individuals with the long GT tandem 
repeat polymorphism of the HMOX1 pro­
moter, and not in individuals with the short 
repeat variant. This polymorphism is thought 
to decrease the inducibility of HMOX1, 
whose protein product is heme oxygenase­1, 
an important antioxidant enzyme (Chahine 
et al. 2007). Furthermore, when examining 
a three­way interaction, the effects of PM2.5 
exposure on HRV were more pronounced in 
individuals with both the long­repeat HMOX1 
polymorphism and the null GSTM1 genotype 
(Chahine et al. 2007).
Additional genes have been examined to 
determine if specific polymorphisms increase 
susceptibility to PM­related health effects. A 
study of the Normative Aging Study cohort 
focused on polymorphisms in the methylene­
tetrahydrofolate reductase gene (MTHFR) at 
codon C677T (i.e., CT/TT MTHFR geno­
types) or the cytoplasmic serine hydroxymethyl­
transferase gene (cSHMT) at codon C1420T 
(i.e., CT/TT cSHMT genotypes) (Baccarelli 
et al. 2008). The enzymes coded by these genes 
are involved in folate metabolism and regulate PM–induced health effects: who is susceptible?
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plasma homocysteine levels, which is a risk 
factor for CVD. The CT/TT MTHFR vari­
ants are linked to reduced enzymatic activity, 
whereas it is unclear whether this is the case 
for the CT/TT cSHMT variants (Lim et al. 
2005). Additionally, MTHFR and cSHMT 
were found to interact such that the effect of 
the MTHFR polymorphism on the risk of 
CVD varied by the cSHMT genotype (Lim 
et al 2005). Baccarelli et al. (2008) found that 
baseline HRV was lower in individuals with the 
CT/TT MTHFR genotypes than in individuals 
with the CC genotype, but they observed no 
relationship between HRV and cSHMT geno­
types. However, the association between HRV 
and PM2.5 exposure was modulated by both 
MTHFR and cSHMT. Specifically, Baccarelli 
et al. (2008) observed a larger HRV reduc­
tion upon PM2.5 exposure in individuals with   
CT/TT MTHFR genotypes or the CC cSHMT 
genotype compared with the CC MTHFR 
genotype or CT/TT cSHMT genotypes. These 
results suggest a protective effect conferred by 
certain gene variants of MTHFR and cSHMT 
on PM­mediated alterations in HRV.
Investigations of polymorphisms of the 
fibrinogen genes (FGA and FGB) have also 
been conducted. Peters et al. (2009) exam­
ined the effect of SNPs in FGA and FGB 
on steady­state levels of plasma fibrinogen. 
Because fibrinogen has been implicated in 
atherothrombosis, it is thought to play a role 
in PM­mediated CVD. In a population of 
myocardial infarction (MI) survivors, an 
increase in plasma fibrinogen levels upon 
PM10 exposure was 8­fold higher in individu­
als with one homozygous minor allele geno­
type than in individuals homozygous for the 
major allele of FGB. Therefore, the combi­
nation of inflammatory effects and higher 
fibrinogen levels attributed to PM exposure in 
individuals with certain polymorphisms could 
increase the risk of PM­related cardiovascular 
effects (Peters et al. 2009).
Collectively, these results suggest that 
the presence of null alleles or specific 
polymorphisms in genes that mediate the anti­
oxidant response, regulate folate metabo  lism, 
or regulate levels of fibrinogen may increase 
susceptibility to PM­related health effects. 
However, in some cases genetic polymor­
phisms may confer protective effects, such as 
those demonstrated for certain GSTP1 vari­
ants. Thus, genetic factors can modulate the 
relationship between ambient PM exposure 
and the development of health effects by either 
increasing or decreasing the risk of a cardiovas­
cular or respiratory outcome.
Obesity
Pulmonary oxidative stress resulting from 
inhaled PM may lead to systemic inflam­
mation and, subsequently, increased cardio­
vascular risk (Dubowsky et al. 2006). As a 
result, studies have recently focused on chronic 
inflammatory conditions, such as obesity, that 
may modulate PM­related health effects. From 
1960 to 2004, the prevalence of overweight 
[body mass index (BMI) ≥ 25.0 kg/m2)] and 
obese (BMI ≥ 30.0 kg/m2) individuals in the 
United States increased from 20% to 74% 
and 13.3% to 32.1%, respectively (National 
Center for Health Statistics 2006).
Numerous studies have examined whether 
individuals who are overweight or obese are 
at increased risk of adverse health effects of 
PM relative to people of normal weight. 
Epidemiological studies reported a reduction 
in HRV in obese compared with nonobese 
subjects upon PM exposure (e.g., Schwartz 
et al. 2005). Additionally, studies observed 
higher levels of inflammatory markers in the 
plasma [i.e., C­reactive protein (CRP), inter­
leukin­6 (IL­6), and white blood cell (WBC) 
count] (Dubowsky et al. 2006) and evidence 
for a larger reduction in FMD (Schneider et al. 
2008) in obese than in nonobese individu­
als in response to short­term PM2.5 exposure. 
Studies of the Veteran’s Normative Aging 
and Women’s Health Initiative cohorts pro­
vided evidence for an increase in inflamma­
tory markers and cardiovascular events, 
respectively, upon long­term PM exposure 
in individuals with BMI ≥ 25 kg/m2 com­
pared with < 25 kg/ m2 (Miller et al. 2007; 
Zeka et al. 2006a). However, an examination 
of associations between 20­year exposures to 
PM10 or PM2.5 and subclinical atherosclerosis 
in the Multi­ethnic Study of Atherosclerosis 
cohort provided no clear evidence for differ­
ences by BMI (i.e., > 30 kg/m2 vs. < 30 kg/m2) 
(Diez Roux et al. 2008). The greater response 
observed in obese individuals to PM expo­
sure could be due, in part, to a higher PM 
dose rate in obese individuals. This has been 
demon  strated in overweight children, where 
an increase in tidal volume and resting min­
ute ventilation was observed with higher BMI 
(Bennett and Zeman 2004).
Preexisting Diseases
The National Research Council (2004) has 
emphasized the need to evaluate the effect of 
air pollution on potentially susceptible popu­
lations, including those with cardiovascular 
and respiratory diseases. Previous reviews of 
the literature suggested that preexisting car­
diopulmonary diseases, as well as diabetes, 
may increase susceptibility to effects of PM 
exposure (U.S. EPA 2004). More recent epi­
demiological and experimental studies have 
built upon these conclusions to provide an 
additional understanding of susceptibility to 
PM­related health effects.
Cardiovascular disease. Epidemiological, 
controlled human exposure, and toxicologi­
cal studies examined whether hypertension, 
conditions associated with coronary artery dis­
ease [CAD; i.e., ischemic heart disease (IHD), 
MI, atherosclerosis], and CHF modulate 
PM­related health effects. Preexisting cardio­
vascular conditions, such as hypertension, heart 
disease, and coronary heart disease, are highly 
prevalent in the U.S. population (Table 1).
Hypertension. Hypertension has often 
been considered in stratified analyses that 
examine the association between short­term 
PM exposure and cardiovascular­related 
Table 1. Percentages of the U.S. population with CVD, respiratory diseases, and diabetes.
Chronic condition/disease
Age (years)
Adults (≥ 18)
18–44 45–64 65–74 ≥ 75
Region
n (× 106) (%) NE MW S W
CVD
All heart diseasea 25.1 11.2 4.1 12.2 27.1 35.8 10.6 12.3 11.3 10.2
Coronary heart diseaseb 13.7 6.1 0.9 6.7 18.6 23.6 5.3 6.7 6.4 5.5
Hypertension 51.6 23.2 8.2 32.1 50.9 57.4 21.3 23.4 25.1 21.0
Stroke 5.4 2.4 0.3 2.8 6.3 10.6 2.2 2.3 2.7 2.2
Respiratory diseases
Asthmac 24.2 11.0 11.5 10.5 11.7 9.3 11.7 11.5 10.5 10.8
COPD
Chronic bronchitis 7.6 3.4 2.3 4.2 5.5 4.8 2.8 3.2 4.0 2.9
Emphysema 3.7 1.6 0.2 2.3 4.5 5.2 1.1 1.8 1.8 1.6
Diabetes 17.2 7.7 2.2 10.6 19.9 17.2 6.3 7.7 8.3 7.6
Abbreviations: NE, Northeast; MW, Midwest; S, South; W, West. All data are from the Centers for the Disease Control and Prevention (2008a, 2008b).
aHeart disease includes coronary heart disease, angina pectoris, heart attack, or any other heart condition or disease. bCoronary heart disease includes coronary heart disease, 
angina pectoris, or heart attack. cPrevalence data are based on adults responding to “ever told had asthma.”Sacks et al.
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hospital admissions and emergency depart­
ment (ED) visits. However, it is unclear 
whether preexisting hypertension modifies 
the associations observed. A study conducted 
in Utah found no evidence for increased risk 
of acute IHD events for PM2.5 exposure in 
individuals with preexisting hypertension 
compared with those without hypertension 
(Pope et al. 2006). This result is consistent 
with other studies where hypertension did not 
modify the association between PM and car­
diovascular outcomes, such as CHF hospital 
admissions (e.g., Wellenius et al. 2006b). In 
contrast, Peel et al. (2007) found that the pres­
ence of preexisting hypertension resulted in an 
increased risk of ED visits for dysrhythmias 
and CHF with PM10 exposure. The potential 
effect of hypertension on the manifestation of 
PM­related cardiovascular effects is supported 
by a toxicological study conducted in a rat 
model of hypertension, which demonstrated 
that PM2.5 CAPs exposure resulted in higher 
mean arterial pressure compared with air 
controls (Sun et al. 2008). This finding sug­
gests a relationship between PM2.5 exposure 
and hypertension that may provide biological 
plausibility for the worsening of hypertension­
related cardiovascular outcomes observed by 
Peel et al. (2007).
CAD. We identified multiple studies that 
examined the effect of preexisting cardio­
vascular conditions associated with CAD on 
PM­related cardiovascular effects. In a panel 
study in Boston, individuals with pre  existing 
IHD were observed to have larger altera­
tions in HRV with PM2.5 exposure than did 
individuals without IHD (Park et al. 2005). 
Toxicological studies using Boston CAPs in 
dogs with induced myocardial ischemia, an ani­
mal model that mimics the patho  physiological 
effects associated with IHD, demonstrated 
increased ST­segment elevation and impaired 
myocardial blood flow in response to PM2.5 
CAPs exposure (Bartoli et al. 2009; Wellenius 
et al. 2003).
Epidemiological, controlled human expo­
sure, and toxicological studies examined the 
effect of previous MI on PM­induced cardio­
vascular effects. Wellenius et al. (2006b) found 
no evidence to suggest a modification of the 
relationship between PM10 and CHF hospital 
admissions by previous acute MI. Controlled 
human exposure studies investigated the 
effects of dilute DE or fine and UF CAPs 
in subjects with CAD and prior MI (Mills 
et al. 2007, 2008). Exposure to fine and UF 
CAPs, which were low in combustion­derived 
particles, did not result in any pronounced 
effects on vascular function (Mills et al. 2008). 
However, exposure to dilute DE promoted 
exercise­induced ST­segment changes, which 
are consistent with myocardial ischemia, and 
inhibited endogenous fibrinolytic capacity 
(Mills et al. 2007). The discrepant results in 
these studies may be due to medication use, 
because individuals with CAD (most on beta 
blockers) exposed to UF carbon particles had 
no change in HRV (Routledge et al. 2006), or 
due to differences in the PM. In a toxicologi­
cal study using an animal model of acute MI, 
rats exposed to PM2.5 CAPs had decreased 
ventricular premature beats and spontaneous 
supraventricular ectopic beats (Wellenius et al. 
2006a). In a rodent MI model of chronic heart 
failure, a prominent increase in the incidence 
of premature ventricular contraction with DE 
exposure was reported (Anselme et al. 2007). 
The discrepancy in health effects observed 
between toxicological studies could be due to 
differences in the MI model or the PM (i.e., 
CAPs vs. DE).
Toxicological studies also examined the 
effects of PM exposure in a murine model 
susceptible to atherosclerosis, the apolipo­
protein knockout (ApoE–/–) mouse, which 
is characterized by systemic oxidative stress. 
ApoE–/– mice acutely exposed to whole gaso­
line emissions resulted in electrocardiogram 
T­wave alterations, which were attributable to 
particles (Campen et al. 2006). Several studies 
reported relatively consistent pathophysiologi­
cal effects when exposing ApoE–/– mice to 
PM2.5 CAPs for several months. Chen and 
Nadziejko (2005) found a greater degree of 
atherosclerosis in ApoE–/– mice than in con­
trol mice after exposure to fine CAPs (from 
Tuxedo, NY). Furthermore, decreased heart 
rate, physical activity, and temperature 
along with biphasic responses in HRV were 
observed in ApoE–/– mice, but not in control 
mice, upon exposure to these CAPs (Chen 
and Hwang 2005). In addition, ApoE–/– mice 
exposed to UF and PM2.5 CAPs (from Los 
Angeles and Tuxedo) had larger athero  sclerotic 
lesions than those exposed to air (e.g., Araujo 
et al. 2008; Sun et al. 2008).
Taken together, the results from toxico­
logical studies using models relevant to CAD 
provide coherence and biological plausibility 
for the epidemiological findings of PM­related 
cardiovascular effects.
CHF. A limited number of epidemio­
logical studies have examined potential effect 
measure modification of PM­related cardio­
vascular effects by comparing individuals 
with and without preexisting CHF. In Utah, 
short­term PM2.5 exposure was associated 
with increased risk of hospital admissions for 
acute IHD events in individuals with pre­
existing CHF (Pope et al. 2006). Additionally, 
a study conducted in Cook County, Illinois, 
showed that individuals with preexisting CHF 
were at increased risk of PM­related mortal­
ity (Bateson and Schwartz 2004). However, a 
large multicity study revealed no evidence of 
increased risk of MI hospital admissions with 
exposure to PM10 in individuals with versus 
without CHF (Zanobetti and Schwartz 2005).
Respiratory diseases. Epidemiological 
studies have examined the effect of preexisting 
respiratory diseases on multiple health out­
comes (e.g., asthma symptoms, mortality) in 
response to PM exposure. In addition, animal 
models have been developed, and controlled 
human exposure studies have examined the 
possible effect of preexisting respiratory con­
ditions on PM­induced health effects in an 
experimental setting. As was true for CVD 
millions of people are affected by respiratory 
diseases (i.e., asthma, COPD, and emphy­
sema) in the United States, which includes 
approximately 9.3% of children < 18 years of 
age that have been diagnosed with asthma (see 
Table 1) (Pleis and Lucas 2009).
Asthma. In epidemiological studies of asth­
matic children, short­term PM2.5 exposure was 
associated with an increase in medication use 
(Rabinovitch et al. 2006) and respiratory 
symptoms (i.e., cough, shortness of breath, 
and chest tightness) (e.g., Gent et al. 2003), 
and short­term PM10 exposure was associ­
ated with morning symptoms (Mortimer et al. 
2002) and respiratory symptoms (Delfino et al. 
2003). Health effects in asthmatic adults have 
also been demonstrated (e.g., asthma attacks 
with short­term PM10 exposure), although the 
evidence is more limited (Desqueyroux et al. 
2002).
Toxicological studies provide coherence 
and biological plausibility for the findings of 
the epidemiological literature. In response to 
an acute exposure to CAPs from Detroit, an 
area with pediatric asthma rates three times 
the national average, rats with allergic airway 
disease exposed to PM derived from local 
combustion sources had eosinophil influx and 
increased bronchoalveolar lavage fluid pro­
tein content (Morishita et al. 2004). These 
findings suggest that the presence of allergic 
airway conditions increases susceptibility to 
allergic airway responses to PM2.5, which may 
be partially attributed to increased pulmonary 
deposition and localization of particles in the 
respiratory tract (Morishita et al. 2004). An 
additional study using rats with allergic airways 
disease exposed to CAPs provided evidence 
for increased expression of genes associated 
with inflammation and airway remodeling 
compared with nonallergic animals exposed 
to CAPs and allergic animals not exposed to 
CAPs (Heidenfelder et al. 2009). Furthermore, 
several toxicological studies demonstrated that 
PM acts as an adjuvant to enhance the severity 
or development of asthma (e.g., Li et al. 2009).
The results from the epidemiological and 
toxicological studies that focused on pre­
existing allergic airways disease are supported 
by a collection of controlled human exposure 
studies demonstrating that exposure to DE 
particles increases the allergic inflammatory 
response in atopic individuals (e.g., Bastain 
et al. 2003; Nordenhäll et al. 2001). However, PM–induced health effects: who is susceptible?
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 4 | April 2011  451
not all controlled human exposure studies 
provided evidence for enhanced respiratory 
effects in asthmatic individuals. For example, 
a series of studies reported that healthy and 
asthmatic subjects exposed to CAPs of three 
different size fractions (PM10–2.5, PM2.5, and 
UF) exhibited similar respiratory responses 
(e.g., Gong et al. 2003, 2004b). However, 
these studies excluded moderate and severe 
asthmatics, which would be expected to show 
increased susceptibility to PM exposure.
COPD. Epidemiological panel studies 
that examined the effect of PM on lung func­
tion demonstrated greater declines in forced 
expiratory volume in 1 sec and forced vital 
capacity in individuals with COPD versus 
those without in response to PM2.5 exposure 
(e.g., Lagorio et al. 2006; Trenga et al. 2006). 
Conversely, in a study involving controlled 
human exposures to PM2.5 CAPs, healthy 
older adults experienced a somewhat greater 
PM­induced respiratory response (decrease 
in arterial oxygen saturation) than did older 
adults with COPD (Gong et al. 2004a). No 
other respiratory effects in response to PM 
exposure (e.g., respiratory symptoms, lung 
function, or airway inflammation) were 
observed in either group.
Dosimetric studies clearly demonstrated 
that COPD patients have increased dose 
rates of fine and UF particles and impaired 
muco  ciliary clearance relative to age­matched 
healthy subjects. These findings suggest 
that individuals with COPD are poten­
tially at greater risk of PM­related health 
effects (Bennett et al. 1997; Brown et al. 
2002). Support for PM­mediated exacerba­
tion of emphysema is provided by a toxico­
logical study using papain­treated mice. In this 
model, exposure to urban ambient air resulted 
in a PM­dependent increase in a measure 
of airspace enlargement (Lopes et al. 2009). 
The pathogenesis of emphysema is a complex 
process involving oxidative stress and inflam­
mation, both of which can result from PM 
deposition in the respiratory tract. Collectively, 
these results provide preliminary evidence for 
biological plausibility of PM­related health 
effects in individuals with COPD and suggest 
that respiratory morbidities, excluding asthma, 
may also increase the susceptibility of a popu­
lation to PM­related respiratory effects.
Respiratory contributions to cardiovascular 
effects. Most studies that examined whether 
preexisting respiratory diseases increase the 
risk of PM­related health effects have focused 
on PM­induced respiratory exacerbations, 
but some studies have also examined whether 
preexisting respiratory diseases contribute to 
cardiovascular effects. Most epidemiological 
studies did not find evidence that preexist­
ing respiratory diseases increased the risk of 
PM­related cardiovascular hospital admission 
or ED visits for a variety of cardiovascular 
outcomes (e.g., IHD, arrhythmias, CHF, 
MI); these studies examined whether preex­
isting respiratory infection (Wellenius et al. 
2006b), pneumonia (Zanobetti and Schwartz 
2005), and COPD (Peel et al. 2007) increased 
the risk of PM­related cardiovascular effects. 
However, De Leon et al. (2003) found that 
individuals with preexisting respiratory dis­
eases had increased risk for PM10­induced cir­
culatory mortality compared with individuals 
without preexisting respiratory diseases.
A controlled human exposure study 
demon  strated acute responses in the cardio­
vascular system and systemic circulation among 
asthmatic individuals, compared with non­
asthmatics, after PM2.5 CAPs exposure (Gong 
et al. 2003). However, respiratory disease does 
not consistently affect cardiovascular response 
to PM exposure in controlled human exposure 
studies (e.g., Fakhri et al. 2009; Gong et al. 
2004b). A toxicological study showed that 
the pulmonary artery lumen­to­wall ratio was 
decreased in an animal model of chronic bron­
chitis in response to PM2.5 CAPs, but a simi­
lar response was also observed in healthy rats 
(Batalha et al. 2002). Whereas the identifica­
tion of characteristics of potentially susceptible 
populations has initially relied on epidemio­
logical evidence, in this instance it is unclear 
how the epidemiological results compare with 
those found in the controlled human expo­
sure and toxicological studies that focused on 
exposure to PM2.5 (e.g., CAPs). Thus, the lack 
of coherence across disciplines clouds whether 
individuals with preexisting respiratory diseases 
represent a population that is potentially sus­
ceptible to PM­related cardiovascular effects.
Diabetes. Numerous studies have evalu­
ated the potential for diabetes, a disease linked 
to chronic inflammation, to increase the risk 
of PM­related health effects. The increased 
interest in this population can be partially 
attributed to the large percentage of diabetic 
individuals in the United States (Table 1).
Epidemiological studies that examined 
whether diabetes modifies the association 
between cardiovascular effects and PM expo­
sure primarily focused on short­term PM10 
exposure. A multicity study showed > 75% 
greater risk of hospitalization for cardiac dis­
eases with PM10 exposure among individuals 
with diabetes than among those without dia­
betes (Zanobetti and Schwartz 2002). A study 
conducted in Atlanta, Georgia, also showed 
increased risk of cardiovascular­related ED vis­
its for PM10 exposure, specifically for IHD, 
arrhythmias, and CHF, among persons with 
diabetes than among those without diabetes 
(Peel et al. 2007). However, other studies (both 
multicity and single city) revealed no evidence 
for increased risk of cardiovascular ED visits 
and hospital admissions for short­term PM2.5 
or PM10 exposure among persons with diabetes 
compared with those without diabetes (Pope 
et al. 2006; Wellenius et al. 2006b; Zanobetti 
and Schwartz 2005). Other evidence from 
epidemiological studies indicates that diabetes 
could potentially increase the risk of mortality 
with exposure to PM2.5 (Goldberg et al. 2006) 
and PM10 (Zeka et al. 2006b).
Additional epidemiological studies, as well 
as controlled human exposure studies, exam­
ined physiological alterations and changes in 
inflammatory and coagulation markers in the 
cardiovascular system of diabetic individuals 
in an attempt to provide biological plausi­
bility for the increased risk of cardiovascular 
effects observed in some of the population­level   
studies. A panel study of individuals with dia­
betes demonstrated that ambient exposure to 
PM2.5 enhanced the reduction in various mark­
ers of endothelial function (Schneider et al. 
2008). Liu et al. (2007) observed an increase 
in alterations in FMD and basal diameter upon 
PM10 exposure in persons with diabetes. On the 
other hand, a controlled human exposure study 
showed that DE elicited no prothrombotic 
effects in subjects with metabolic syndrome, 
which is characterized by alterations in physi­
ological parameters and inflammatory markers 
similar to those observed in individuals with 
diabetes (Carlsten et al. 2008). An examination 
of biomarkers in individuals with diabetes who 
were exposed to PM revealed mixed results, 
including an increase in von Willebrand factor 
(Liao et al. 2005), an increase in thiobarbituric 
acid but no increases in CRP or tumor necrosis 
factor­α (Liu et al. 2007), and an increase in 
CRP and WBC count (Dubowsky et al. 2006). 
Although it is unclear how alterations in each of 
these biomarkers contribute to the potential for 
cardiovascular effects in individuals with dia­
betes, PM­induced changes in inflammation, 
oxidative stress, and acute­phase response may 
lead to more severe cardiovascular effects.
Socioeconomic Status
In 2009, approximately 14.3% of the U.S. 
population was living in poverty (U.S. Census 
2010). Although there are numerous indicators 
of SES, including economic status measured 
by income, social status measured by educa­
tion, and work status measured by occupa­
tion, each of these linked factors can influence 
a population’s susceptibility to PM­related 
health effects (Dutton and Levine 1989). Low 
SES is associated with a higher prevalence of 
preexisting diseases, limited access to medical 
care, and limited access to fresh foods leading 
to a reduced intake of polyunsaturated fatty 
acids and vitamins, all of which may contrib­
ute to increased susceptibility to PM­induced 
health effects (Kan et al. 2008).
Indicators of SES were demonstrated 
in some epidemiological studies to modify 
health outcomes associated with PM expo­
sure. In these studies, SES has primarily 
been defined at the neighborhood level (e.g., Sacks et al.
452  v o l u m e  119 | n u m b e r 4 | April 2011  •  Environmental Health Perspectives
educational attainment or income within 
a neighborhood) to identify low, medium, 
and high SES areas within a study location. 
Educational attainment generally coincides 
with an individual’s income, which is cor­
related with other indicators of SES, such as 
residential environment (Jerrett et al. 2004). 
Epidemiological studies reported increased 
risk of mortality for short­term exposure to 
PM2.5 and PM2.5 components in low­SES 
groups (i.e., examined by median household 
income) (Franklin et al. 2008), whereas other 
analyses demonstrated consistent trends of 
increased mortality associations with PM2.5, 
PM2.5 species, and PM10–2.5 for low edu­
cational attainment groups (i.e., ≥ high 
school vs. < high school education) (Ostro 
et al. 2006, 2008; Zeka et al. 2006b). In the 
American Cancer Society cohort, increased 
lung cancer mortality with long­term PM2.5 
exposure was observed among the subgroup 
with a high school education or less compared 
with groups with more than a high school 
education (Krewski et al. 2009). However, 
when examining PM2.5­related IHD mortal­
ity by education level, the reverse relationship 
was observed (Krewski et al. 2009).
Epidemiological studies also examined other 
indicators of SES, such as residential location 
and nutritional status, to identify their influ­
ence on the PM–health effect association. An 
examination of the potential modification of 
acute mortality effects due to PM exposure by 
residential location in Hamilton, Canada, using 
educational attainment as an indicator for SES 
revealed that the areas of the city with the high­
est SES displayed no evidence of effect measure 
modification, whereas the areas with the low­
est SES had the largest mortality risks (Jerrett 
et al. 2004). Likewise, a study conducted in 
Phoenix used educational attainment (i.e., 
percentage of population with less than a high 
school diploma) and income (i.e., percentage 
of population with income below the poverty 
level) to represent SES (Wilson et al. 2007); 
the area with the lowest SES had the strongest 
association between PM2.5 and cardiovascular 
mortality, but the association differed when 
examining PM10–2.5, with the strongest asso­
ciation being observed for the area with higher 
educational attainment and income.
Another consequence of low SES may 
be decreased access to fresh foods. The effect 
of nutritional deficiencies was examined in a 
study of individuals with polymorphisms in 
genes associated with increased risk of CVD 
(Baccarelli et al. 2008). Individuals who 
had these genetic polymorphisms and who 
increased their intake (above median levels) of 
B6, B12, or methionine did not have alterations 
in HRV in response to PM2.5 exposure, in con­
trast to those individuals who did not increase 
nutrient intake (Baccarelli et al. 2008).
Conclusion
Epidemiological studies have examined charac­
teristics of populations that may render them 
more susceptible to PM­related health effects 
by conducting stratified analyses. By also con­
sidering experimental studies that examined 
individuals with an underlying health condi­
tion or used animal models of disease, it is 
possible to more thoroughly evaluate charac­
teristics that may lead to increased susceptibil­
ity. The collective evidence across disciplines 
indicates that some characteristics, including 
life stage, genetic polymorphisms, pre  existing 
cardiovascular and respiratory diseases, and 
SES, may increase the susceptibility of popula­
tions to PM­related health effects (Table 2). 
Additional characteristics (e.g., obesity and 
diabetes) were also identified.
A limitation of this review, as described 
throughout, is the inability to clearly state 
the overall strength of the evidence for some 
charac  teristics of potentially susceptible popu­
lations because of inconsistency in the evi­
dence across epidemiological studies or lack 
of information from experimental studies 
regarding biologically plausible mechanisms. It 
has been noted, specifically in a recent review 
involving controlled human exposures to PM 
among potentially susceptible groups, that the 
relative lack of evidence of increased suscep­
tibility may be due to a host of factors, such 
as medication use of the volunteers, subject 
selection bias, and nonspecificity of study end 
points, and not necessarily because these indi­
viduals did not represent populations suscep­
tible to PM­related health effects (Huang and 
Ghio 2009). As a result, the collective evidence 
discussed within this review may not clearly 
identify all the characteristics of populations 
susceptible to PM­related health effects.
To assist in the identification of popula­
tions at increased risk for PM­related health 
effects, a consistent definition of susceptibility 
is needed. The ambiguity in the use of terms, 
including “susceptibility,” “vulnerability,” and 
“sensitivity,” across studies has to an extent 
increased the difficulty in focusing on the 
populations that have a greater likelihood of 
experiencing PM­related health effects. In the 
future, an approach similar to the one used in 
this review may allow the scientific commu­
nity to focus on identifying the populations 
at increased risk to an air pollutant, regard­
less of their classification (e.g., susceptible, 
vulnerable, sensitive).
Overall, the epidemiological studies evalu­
ated in this review, with supporting evidence 
from controlled human exposure and toxi­
cological studies, identified characteristics of 
populations that may lead to increased sus­
ceptibility to PM­related health effects. This 
includes life stage, specifically children and 
older adults; preexisting cardiovascular (i.e., 
CAD) and respiratory (i.e., asthma) diseases; 
genetic polymorphisms; and low SES, as meas­
ured by educational attainment and income. 
Additionally, more limited evidence sug­
gests an increase in PM­related health effects 
in individuals with diabetes, COPD, and 
increased BMI. Although not clearly estab­
lished, the evidence evaluated also indicated 
potentially increased risk of PM­related health 
effects by sex and race/ethnicity, but these 
associations were not consistent across PM 
size fractions, health effects, and in some cases 
study locations. Overall, additional research 
is warranted to more accurately identify the 
characteristics of potentially susceptible popu­
lations and the biologically plausible mech­
anisms that result in one population being 
more susceptible than another to PM­related 
health effects. In addition, future research may 
enable the identification of specific PM size 
fractions, sources, or components that render 
a population more susceptible.
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